|Quantitative T 2* assessment of acute and chronic myocardial ischemia/reperfusion injury in mice.|
|Jump to Full Text|
|PMID: 22327962 Owner: NLM Status: MEDLINE|
|OBJECT: Imaging of myocardial infarct composition is essential to assess efficacy of emerging therapeutics. T (2) (*) mapping has the potential to image myocardial hemorrhage and fibrosis by virtue of its short T (2) (*) . We aimed to quantify T (2) (*) in acute and chronic myocardial ischemia/reperfusion (I/R) injury in mice.
MATERIALS AND METHODS: I/R-injury was induced in C57BL/6 mice (n = 9). Sham-operated mice (n = 8) served as controls. MRI was performed at baseline, and 1, 7 and 28 days after surgery. MRI at 9.4 T consisted of Cine, T (2) (*) mapping and late-gadolinium-enhancement (LGE). Mice (n = 6) were histologically assessed for hemorrhage and collagen in the fibrotic scar.
RESULTS: Baseline T (2) (*) values were 17.1 ± 2.0 ms. At day 1, LGE displayed a homogeneous infarct enhancement. T (2) (*) in infarct (12.0 ± 1.1 ms) and remote myocardium (13.9 ± 0.8 ms) was lower than at baseline. On days 7 and 28, LGE was heterogeneous. T (2) (*) in the infarct decreased to 7.9 ± 0.7 and 6.4 ± 0.7 ms, whereas T (2) (*) values in the remote myocardium were 14.2 ± 1.1 and 15.6 ± 1.0 ms. Histology revealed deposition of iron and collagen in parallel with decreased T (2) (*) .
CONCLUSION: T (2) (*) values are dynamic during infarct development and decrease significantly during scar maturation. In the acute phase, T (2) (*) values in infarcted myocardium differ significantly from those in the chronic phase. T (2) (*) mapping was able to confirm the presence of a chronic infarction in cases where LGE was inconclusive. Hence, T (2) (*) may be used to discriminate between acute and chronic infarctions.
|Eissa N E Aguor; Fatih Arslan; Cees W A van de Kolk; Marcel G J Nederhoff; Pieter A Doevendans; Cees J A van Echteld; Gerard Pasterkamp; Gustav J Strijkers|
|Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2012-02-11|
|Title: Magma (New York, N.Y.) Volume: 25 ISSN: 1352-8661 ISO Abbreviation: MAGMA Publication Date: 2012 Oct|
|Created Date: 2012-09-26 Completed Date: 2013-02-20 Revised Date: 2014-01-20|
Medline Journal Info:
|Nlm Unique ID: 9310752 Medline TA: MAGMA Country: Germany|
|Languages: eng Pagination: 369-79 Citation Subset: IM|
|APA/MLA Format Download EndNote Download BibTex|
Collagen / chemistry
Disease Models, Animal
Fibrosis / pathology
Heart Ventricles / pathology
Hemorrhage / diagnosis
Iron / chemistry
Magnetic Resonance Imaging, Cine / methods*
Mice, Inbred C57BL
Myocardial Infarction / complications, pathology*
Myocardial Reperfusion Injury / pathology*
Myocardium / pathology
Journal ID (nlm-ta): MAGMA
Journal ID (iso-abbrev): MAGMA
Publisher: Springer-Verlag, Berlin/Heidelberg
© The Author(s) 2012
Received Day: 16 Month: 12 Year: 2011
Revision Received Day: 21 Month: 1 Year: 2012
Accepted Day: 23 Month: 1 Year: 2012
Electronic publication date: Day: 11 Month: 2 Year: 2012
pmc-release publication date: Day: 11 Month: 2 Year: 2012
Print publication date: Month: 10 Year: 2012
Volume: 25 Issue: 5
First Page: 369 Last Page: 379
PubMed Id: 22327962
Publisher Id: 304
|Quantitative T2* assessment of acute and chronic myocardial ischemia/reperfusion injury in mice|
|Eissa N. E. Aguor123|
Address: +31-88755-7155 +31-30252-2693 firstname.lastname@example.org
|Cees W. A. van de Kolk1|
|Marcel G. J. Nederhoff23|
|Pieter A. Doevendans13|
|Cees J. A. van Echteld1|
|Gustav J. Strijkers4|
1Department of Cardiology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands
2Laboratory of Experimental Cardiology, University Medical Center Utrecht (UMCU), Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
3The Netherlands Heart Institute, Utrecht, The Netherlands
4Biomedical NMR, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
Despite recent advances in therapeutics and diagnostics, morbidity and mortality after myocardial infarction (MI) remains a great socio-economic burden in Western societies. Early identification of patients with sub-optimal cardiac recovery is of great importance to improve clinical management. For this reason, both functional and structural characterization of the infarcted myocardium is important for risk stratification of patients after MI.
Technological advances in cardiovascular magnetic resonance (CMR) have demonstrated different ways to track and characterize MI at different time points [1–6]. CMR has been applied to analyze inflammation, edema, necrosis, fibrosis, left-ventricular (LV) remodeling and metabolism in MI [7–15]. Pathological changes in the injured myocardium, such as the presence of fibrosis, hemorrhage and edema, influence the signal intensity on T1-and T2-weighted imaging [7, 16–18]. CMR is thus considered as one of the most important imaging tools in the assessment of the heart after MI.
Typically, T1-weighted imaging is performed some time after injecting a gadolinium-based contrast agent to delineate injured myocardium in a late gadolinium enhancement (LGE) scan . The enhancement mechanism of infarcted tissue is related to the extent of the extracellular volume, which is associated with the delayed washout relative to the healthy myocardium. LGE is widely used and, without competition, considered the gold standard to assess infarct size. Nevertheless, there are certain limitations of LGE related to pathological processes after the onset of infarction. In the acute and sub-acute phase after successful reperfusion of the ischemic myocardium, the transmural infarct extent is not stable and an overestimation of infarct size has been reported . In the chronic phase, excessive and heterogeneous collagen deposition during scar maturation may hamper signal enhancement by LGE.
In view of the above limitations, several alternative contrast mechanisms are explored to study the pathophysiological changes in the injured myocardium. The sensitivity of the T2 relaxation time to myocardial water content has led to the application of T2-weighted CMR protocols to image myocardial edema as an indicator of inflammation and necrosis in acute MI [13, 15, 21–24]. T2* contrast has been explored as a tool to diagnose the presence of hemorrhage and myocardial iron [1–5, 25–28]. Recently, it was demonstrated that T2* has the potential to image fibrosis in the infarct zone using an ultra-short echo time (UTE) technique .
In this paper, we hypothesize that the structural and pathological changes in acute and chronic MI, such as the presence and development of myocardial hemorrhage and fibrotic tissue progressively influence T2* values in the infarcted myocardium. To investigate this, we quantified T2* using a T2*-mapping protocol longitudinally in acute and chronic ischemia/reperfusion (I/R) infarcts in mice. We explored the utility of T2* mapping as a complementary tool to LGE to characterize the infarcted myocardium.
C57Bl6/J mice (n = 23, body weight = 20–25 g) were used in this study. CMR measurements were performed at baseline (BL), 1 day (acute infarct), 7 and 28 days (chronic infarct) after induction of MI by 30 min transient ligation of the left coronary artery (LCA) (n = 9). A sham-operated group (n = 8) served as control. The CMR protocol for the infarct group consisted of a multi-gradient-echo quantitative T2*-mapping sequence, traditional LGE to assess the location and size of the infarct, and gradient-echo Cine imaging to determine cardiac function. The sham-operated (control) group underwent gradient-echo Cine imaging only to evaluate cardiac function. In the first group of nine mice with MI, one mouse died at day 28 during the CMR scan. Another three mice of this group presented a small infarct on LGE images at day 1, but no chronic myocardial infarct at day 7 and 28 (as exemplified in Fig. 3). A separate set of mice with MI (n = 6) were killed either at day 1 (n = 2), 7 (n = 2), or 28 (n = 2) for the histopathological characterization of myocardial tissues. All animal experiments were performed in accordance with the national guidelines on animal care and with prior approval by the Animal Experimentation Committee of Utrecht University.
Mice underwent myocardial I/R surgery as previously described . Briefly, mice were anesthetized with a mixture of Fentanyl (Jansen-Cilag) 0.05 mg/kg, Dormicum (Roche) 5 mg/kg, and medetomidine 0.5 mg/kg through an intraperitoneal injection. A core body temperature of about 37°C was maintained during surgery by continuous monitoring with a rectal thermometer and an automatic heating blanket. Mice were intubated and ventilated (Harvard Apparatus Inc, Holliston, MA) with 100% oxygen. The LCA was ligated for 30 min with an 8-0 Ethilon (Ethicon) suture with a section of polyethylene-10 tubing placed over the LCA. Ischemia was confirmed by bleaching of the myocardium and ventricular tachyarrhythmia. Reperfusion was initiated by release of the ligature and removal of the polyethylene-10 tubing. In sham-operated animals, the suture was placed beneath the LCA without ligation. Reperfusion of the endangered myocardium was characterized by typical hyperemia in the first few minutes. The chest wall was closed, and the animals subcutaneously received Antisedan (Pfizer) 2.5 mg/kg, Anexate (Roche) 0.5 mg/kg, and Temgesic (Schering-Plough) 0.1 mg/kg.
A vertical 9.4 T and 89-mm-diameter bore scanner was used, equipped with 1,500 mT/m gradients (Bruker BioSpin GmbH, Ettlingen, Germany). Mice were anesthetized with 1.5–3 vol% isoflurane in a 2:1 mixture of air (0.3 l/min) and oxygen (0.15 l/min). The mice were put on a custom-built cradle and positioned inside a 3-cm-diameter quadrature volume coil. During the CMR examination anesthesia was maintained at 1.5–2.5 vol% isoflurane to keep the respiratory rate at 50–60 bpm. We did not use ECG leads for cardiac triggering but derived both cardiac and respiratory motion signals from a pressure pad placed under the chest of the mouse.
The CMR protocol consisted of the following steps. After global shimming and RF pulse calibration, 2- and 4-chamber view scout scans were made to plan a single mid-cavity short-axis slice. Cine imaging was performed with a retrospectively-triggered (self-gated) gradient-echo sequence , with the following parameters: TR = 6.8 ms, TE = 1.9 ms, number of movie frames = 15, slice thickness = 1 mm, matrix = 256 × 256, field-of-view = 3 × 3 cm2. Because of the slight difference of hearts size between mice and the dilation of each heart after infarction, seven to nine short-axis slices with inter-slice distance of 1 mm and no slice gap were measured to cover the heart from apex to base. Based on the Cine short-axis images, a mid axial slice was selected that included an area of remote viable tissue as well as a substantial infarct area. T2* mapping was performed in this slice using a cardiac-triggered multi-gradient-echo sequence with the following parameters: TR = R–R interval, TE = 1.22, 3.45, 5.68, 7.91, 10.14, and 12.37 ms, slice thickness = 1 mm, matrix = 128 × 128, field-of-view = 3 × 3 cm2. The trigger delay was chosen in the mid-diastolic rest period of the heart cycle observed in the Cine series. The acquisition window of less than 13 ms resulted in images, which were sufficiently co-registered for the different echo times to allow for a pixel-wise T2* determination (Fig. 1) . LGE scans were performed in the same slice with a cardiac-triggered inversion-recovery segmented gradient-echo sequence, with the following parameters: TR = 5.8 ms, TE = 2.2 ms, number of segments = 16, slice thickness = 1 mm, matrix = 256 × 256, field-of-view = 3 × 3 cm2. The inversion time (TI) was optimized to null the signal from remote myocardium [33, 34]. Gadobutrol (Gadovist, Bayer Schering Pharma AG, Berlin, Germany) dose of 1 mmol/ml was used. To reduce volume related variability, contrast agent was diluted 1:4 with a standard saline solution. This dilution resulted in administered weight-adapted volume of 2 μl/g body weight, resulting in an equivalent dose of 0.5 mmol/kg body weight . The contrast agent was injected intravenously through the tail vein, using a 24-gauge catheter.
T2* maps were generated in Mathematica 7 (Wolfram Research, Champaign, IL, USA) by pixel-wise fittings of the multi-gradient-echo signal intensities to the equation [
For histological evaluation a 1.5-mm-thick slice containing infarcted myocardium was fixed in 4% formalin and paraffin-embedded. Hereafter, 5-μm-thick sections were mounted on glass slides and stained with Picrosirius red staining for collagen, Prussian blue staining for iron, and Hematoxylin-Eosin (HE) for cellular structures. The stained sections were photographed with a digital image microscopy using white or polarized light.
All statistical analysis was evaluated using (SPSS 17 for Windows; SPSS). Results were expressed as mean ± standard deviation for each group of animals. An independent two-tailed sample t test and the Mann–Whitney exact two-tailed U test were performed to compare mean values in subjects for each time point post MI versus baseline. Results were considered statistically significant for a p value of less than 0.05. The correlation analysis of T2* values against WT was performed using linear regression.
An image series of a mid-axial slice with varying TE for a representative mouse at baseline is shown in Fig. 1a. The LV myocardium was well co-registered for the different images. Signal loss due to susceptibility differences was occasionally observed for the images with the longest TE. Pixel-wise fitting of the signal intensities in the LV myocardium as function of TE resulted in a T2* map as shown in Fig. 1b. T2* values were homogeneous throughout the LV myocardial wall and consistent between mice, with a mean T2* value of 17.1 ± 2.0 ms in the free wall.
Figure 2 displays a collection of images, consisting of LGE, T2* maps, and Cine images at diastole, for a representative mouse at day 1, 7 and 28 after induction of the MI. On day 1, LGE resulted in a homogeneous enhancement of the infarct in the mid-anterior and mid-anterolateral wall, whereas on days 7 and 28 enhanced area was smaller, heterogeneous, and difficult to detect. Corresponding T2* maps revealed a different picture. At day 1, a significant change in T2* could be detected in the LGE-based infarct area. Further, at days 7 and 28, T2* dramatically decreased, particularly in the mid-anterolateral region indicating the existence of a significant infarct. The presence of an infarct was further corroborated by the Cine images, which showed increased WT in the mid-anterior and mid-anterolateral wall at day 1, followed by progressive thinning below baseline levels at days 7 and 28, respectively.
Figure 3 shows LGE and T2* maps of one of three mice with a small infarct in the mid-anterolateral wall, as indicated by a small area of LGE at day 1. Gadolinium enhancement could not be detected anymore at days 7 and 28. In the first group of n = 9 mice with MI, n = 3 mice displayed this atypical behavior. Presumably, LGE at day 1 revealed a small area at risk that could not be detected in the chronic phase. Importantly, T2* values in the mid-anterolateral wall also remained unaffected throughout infarct healing and did not deviate from baseline values.
Quantitative T2* values (n = 5 mice, Fig. 4) were dynamic throughout infarct development. In the infarct, quantitative T2* values decreased significantly (p < 0.05) from baseline (17.1 ± 2.0 ms) to day 1 (12.0 ± 1.1 ms) followed by a further decrease (p < 0.005) both at day 7 (7.9 ± 1.0 ms) and day 28 (6.4 ± 0.7 ms). In addition, the mid-septal (remote) area showed a significant (p < 0.05) decrease of T2* values from baseline (18.2 ± 2.0 ms) to day 1 (13.9 ± 0.8 ms), then slightly recovered at day 7 (14.2 ± 1.1 ms) and day 28 (15.6 ± 1.0 ms).
Global cardiac function of both infarct and sham-operated groups was assessed by Cine imaging (Fig. 5a–c). The infarct group displayed a progressive and significant increase in EDV and ESV, indicative for a considerable dilation of the heart due to the infarct. For the sham-operated group no significant changes in EDV and ESV upon time after surgery were observed. The infarct group presented a decline in EF from 54 ± 3% at baseline to 39 ± 2%, 28 days after surgery (Fig. 5c). For the sham-operated group, EF was slightly elevated at day 1; however, it normalized at day 7 and 28 after surgery. Group-averaged (n = 5) infarct sizes from LGE analysis of a mid-ventricular slice as function of days after surgery are presented in Fig. 5d. At day 1, LGE revealed an average infarct size of 41 ± 6%, dropping to 26 ± 3 and 22 ± 4 % (p < 0.05, compared to day 1) of the LV area at days 7 and 28, respectively, which could be related to infarct resorption over time .
In the infarct group, WT in the free wall (infarct area) showed a significant (p < 0.005) transient increase day 1 after MI, followed by progressive thinning (Fig. 6a). Decreased WT in the infarct paralleled a decrease of the quantitative T2* values (Fig. 4). The mid-septal (remote) area in the infarct group showed no significant changes in WT. In line with the increased WT of the free wall at day 1, the SWT, as a measure of local systolic function, also displayed a transient depression 1 day after surgery, only partially recovering at days 7 and 28 (Fig. 6b). Also, SWT of the remote area was slightly depressed at all time points compared to baseline. The sham-operated group revealed no significant changes in both WT and SWT as function of days after surgery (Fig. 6c, d). WT in the infarct correlated positively and significantly with T2* (Fig. 7). Thus, the chronic MI is characterized by a lower T2* value compared to the acute MI.
Since T2* changes are related to the structural and compositional changes in the infarct myocardial tissue, we performed histology at each time point after I/R injury. Figure 8 shows images of three representative mice at day 1, 7 and 28 after MI. Picrosirius staining (Fig. 8a) revealed no collagen deposits in the infarct area at day 1. At day 7 substantial collagen deposition was observed, followed by a significant increase at day 28. Sections stained with Prussian Blue showed scattered spots of iron as early as 1 day after MI (Fig. 8b). Iron deposition became more prominent at day 7 and further increased at day 28. Finally, on sections stained with HE (Fig. 8c) the infarct area on day 1 was characterized by infiltration of inflammatory cells.
In this study we aimed to systematically study quantitative changes in T2* of the mouse myocardium up to 28 days post I/R injury and to evaluate its added value in characterizing chronic infarcts in comparison to commonly applied LGE and Cine imaging. Combining different CMR techniques, if interpreted carefully, are a potential advantage in the evaluation of the pathophysiological changes in the injured myocardium. Baseline T2* values were comparable to T2 values found at 9.4 T  and 11.75 T , which suggests that decay due to static magnetic field inhomogeneities is largely absent in the healthy myocardium. We found that quantitative T2* values decreased progressively during infarct development. Throughout the observation period, the local decrease of T2* in the infarct was accompanied by globally and locally reduced ventricular function (Figs. 4, 5, 6, 7). The reduction in T2* with infarct age could be explained by the presence of iron (Fig. 8a) [3, 38]. Additionally, the formation of significant amounts of collagen (Fig. 8b) may contribute to the progressive decline of T2* with infarct age .
LGE imaging is currently unchallenged the gold standard technique to assess infarct size. Nevertheless, in certain cases when LGE imaging is inconclusive, additional characterization of the infarct by T2* imaging could provide complementary information. In the acute phase after I/R injury LGE-based infarct size may be inaccurate , when there is loss of cell membrane integrity , an inflammatory response [40, 41], necrosis, hemorrhage, micro-vascular obstruction (MVO) and edema. Indeed, for the acute infarcts at day 1 we found a large LGE-based infarct size accompanied by increased wall-thickness, suggesting the presence of edema. We did not observe a transient increase in T2* at day 1 by the presence of this edema, as previously observed with T2-weighted imaging . The effect of edema on T2* is apparently lower than the decrease of T2* induced by iron or collagen (Fig. 8). This observation is critical in the clinical setting where early assessment of viability is significantly hampered by the presence of infarct-induced edema. T2*-imaging may be a tool to circumvent this inevitable problem after acute MI.
In the chronic infarct, the formation of scar tissue could be responsible for a reduced distribution volume for the extracellular contrast agent. In turn, reduced distribution volume leads to an apparent reduction in infarct size and inhomogeneous enhancement (Figs. 2, 5). Additionally, the extremely low T2* in the infarct (Fig. 2), which locally decreased down to a few milliseconds, could effectively null the signal of the inversion recovery gradient-echo sequence with an echo time of 2.2 ms, obscuring the LGE .
At day 1, a significant decrease of T2* (Fig. 4) and a transient depression of systolic performance (SWT; Fig. 6) were found not only in the infarct, but also to a lesser extent in the remote myocardium. This could be a secondary response in parallel to the structural changes in the infarct region. These findings are in agreement with those of Bogaert et al.  who observed a dysfunction in the remote area at 5 ± 2 days after reperfusion in patients with transmural anterior MI. Others have also shown that remodeling is initiated in the remote myocardium as early as 1 day after I/R injury [44–47].
Comparing Figs. 2 and 3 makes an interesting case. Figure 2 presented an example of a mouse with a considerable infarct at day 1, based on a large LGE positive area. However, at days 7 and 28, the infarct was difficult to detect on LGE, from which one could jump to the conclusion that a considerable part of the area at risk at day 1 recovered at later time points. However, the T2* maps at day 7 and 28 revealed low T2* values in the infarct area, indicating that the infarct was not recovered. The presence of non-viable myocardium (not detected by LGE) was confirmed by akinesia of that area and locally suppressed systolic thickening (SWT) in Cine imaging. Figure 3, conversely, showed one of three mice that presented a small infarct by LGE at day 1, but displayed no positive enhancement at day 7 and 28. For this mouse T2* in the infarct region was preserved during follow-up, indicating that for this mouse the initial area at risk recovered at later time points, as confirmed by healthy LV function. Thus, T2* is able to provide additional information, complementary to LGE, about the myocardial viability after infarction. Taken together, these findings suggest that T2* can be used as a surrogate marker for myocardial recovery during follow-up after MI.
A limitation to the use of T2* as a diagnostic marker for myocardial injury is contamination of intrinsic T2* values by the presence of macroscopic susceptibility differences, mainly present at the air-lung interfaces [26, 27]. Occasionally, we observed lowered T2* values at the lung-heart interface (see for example Fig. 3) in areas with no infarct and no wall-motion abnormalities. Estimations of infarct sizes on the basis of T2* reduction were therefore inaccurate. Also the orientation of the heart with respect to the magnetic field could alter absolute T2* values. Improvements in local shimming techniques might alleviate some of these susceptibility contaminations. Still, use of T2* mapping as a stand-alone technique without the complementary information from LGE is undesired.
Imaging of the myocardium with a T2*-mapping technique in a mouse model of myocardial I/R injury provides useful and complementary information to LGE and Cine imaging. The changes of the T2* were associated with the infarct age, reversibility of the injury, and gave an indication of the structural variation in the myocardium throughout infarct maturation. T2* decrease in the infarcts was associated with iron and collagen depositions. In cases where LGE was inconclusive, T2* mapping was able to confirm the presence of a chronic myocardial scar in mice. Taken together, T2* mapping may provide important additional information on myocardial viability in the acute and chronic phase and scar maturation after acute MI.
This research is supported by the Netherlands Heart Foundation (NHS) grant 2006B066 (CvE) and 2010T001 (FA), as well as by the Netherlands Heart Institute (ICIN). The work of GJS is supported by the Dutch Technology Foundation STW, Applied Science Division of NWO and the Technology Program of the Ministry of Economic Affairs (grant number 07952). We would like to thank Maringa Emons and Chaylendra Strijder for biotechnical assistance and histology.
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
|1..||Saraste A,Nekolla S,Schwaiger M. Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viabilityJ Nucl CardiolYear: 200815110511710.1007/BF0297690218242487|
|2..||Schulz-Menger J,Gross M,Messroghli D,Uhlich F,Dietz R,Friedrich MG. Cardiovascular magnetic resonance of acute myocardial infarction at a very early stageJ Am Coll CardiolYear: 200342351351810.1016/S0735-1097(03)00717-412906982|
|3..||Bos EJ,Baks T,Moelker AD,Kerver W,Geuns RJ,Giessen WJ,Duncker DJ,Wielopolski PA. Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking?Eur Heart JYear: 200627131620162610.1093/eurheartj/ehl05916751204|
|4..||Walsh TF,Hundley WG. Assessment of ventricular function with cardiovascular magnetic resonanceMagn Reson Imaging Clin N AmYear: 200715448750410.1016/j.mric.2007.08.00617976588|
|5..||Sosnovik DE,Nahrendorf M,Weissleder R. Molecular magnetic resonance imaging in cardiovascular medicineCirculationYear: 2007115152076208610.1161/CIRCULATIONAHA.106.65893017438163|
|6..||Bilchick KC,Dimaano V,Wu KC,Helm RH,Weiss RG,Lima JA,Berger RD,Tomaselli GF,Bluemke DA,Halperin HR,Abraham T,Kass DA,Lardo AC. Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapyJACC Cardiovasc ImagingYear: 20081556156810.1016/j.jcmg.2008.04.01319356481|
|7..||Eitel I,Friedrich MG. T2-weighted cardiovascular magnetic resonance in acute cardiac diseaseJ Cardiovasc Magn ResonYear: 20111311310.1186/1532-429X-13-1321332972|
|8..||Raman SV,Simonetti OP,Winner MW III,Dickerson JA,He X,Mazzaferri EL Jr,Ambrosio G. Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndromeJ Am Coll CardiolYear: 201055222480248810.1016/j.jacc.2010.01.04720510215|
|9..||Edwards NC,Routledge H,Steeds RP. T2-weighted magnetic resonance imaging to assess myocardial oedema in ischaemic heart diseaseHeartYear: 200995161357136110.1136/hrt.2009.16996119447836|
|10..||Bandettini WP,Arai AE. Advances in clinical applications of cardiovascular magnetic resonance imagingHeartYear: 200894111485149510.1136/hrt.2007.11901618208827|
|11..||Saborowski O,Saeed M. An overview on the advances in cardiovascular interventional MR imagingMagn Reson Mater PhyYear: 200720311712710.1007/s10334-007-0074-2|
|12..||Gouya H,Vignaux O,Roux P,Chanson P,Bertherat J,Bertagna X,Legmann P. Rapidly reversible myocardial edema in patients with acromegaly: assessment with ultrafast T2 mapping in a single-breath-hold MRI sequenceAJR Am J RoentgenolYear: 200819061576158210.2214/AJR.07.203118492909|
|13..||Mikami Y,Sakuma H,Nagata M,Ishida M,Kurita T,Komuro I,Ito M. Relation between signal intensity on T2-weighted MR images and presence of microvascular obstruction in patients with acute myocardial infarctionAJR Am J RoentgenolYear: 20091934W321W32610.2214/AJR.09.233519770302|
|14..||Giri S,Chung YC,Merchant A,Mihai G,Rajagopalan S,Raman SV,Simonetti OP. T2 quantification for improved detection of myocardial edemaJ Cardiovasc Magn ResonYear: 20091115610.1186/1532-429X-11-5620042111|
|15..||Stork A,Muellerleile K,Bansmann PM,Graessner J,Kaul M,Kemper J,Adam G,Lund GK. Value of T2-weighted, first-pass and delayed enhancement, and cine CMR to differentiate between acute and chronic myocardial infarctionEur RadiolYear: 200717361061710.1007/s00330-006-0460-617149626|
|16..||Abdel-Aty H,Zagrosek A,Schulz-Menger J,Taylor AJ,Messroghli D,Kumar A,Gross M,Dietz R,Friedrich MG. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarctionCirculationYear: 2004109202411241610.1161/01.CIR.0000127428.10985.C615123531|
|17..||Berry C,Kellman P,Mancini C,Chen MY,Bandettini WP,Lowrey T,Hsu LY,Aletras AH,Arai AE. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarctionCirc Cardiovasc ImagingYear: 20103552753510.1161/CIRCIMAGING.109.90076120631034|
|18..||Mewton N,Liu CY,Croisille P,Bluemke D,Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonanceJ Am Coll CardiolYear: 201157889190310.1016/j.jacc.2010.11.01321329834|
|19..||Ibrahim T,Hackl T,Nekolla SG,Breuer M,Feldmair M,Schomig A,Schwaiger M. Acute myocardial infarction: serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusionRadiologyYear: 20102541889710.1148/radiol.0909066020032144|
|20..||Merten C,Steen H,Kulke C,Giannitsis E,Katus HA. Contrast-enhanced magnetic resonance imaging reveals early decrease of transmural extent of reperfused acute myocardial infarctionClin Res CardiolYear: 2008971291391610.1007/s00392-008-0710-518853097|
|21..||Wright J,Adriaenssens T,Dymarkowski S,Desmet W,Bogaert J. Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiographyJACC Cardiovasc ImagingYear: 20092782583110.1016/j.jcmg.2009.02.01119608131|
|22..||Ibanez B,Prat-Gonzalez S,Speidl WS,Vilahur G,Pinero A,Cimmino G,Garcia MJ,Fuster V,Sanz J,Badimon JJ. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonanceCirculationYear: 2007115232909291610.1161/CIRCULATIONAHA.106.67963917515460|
|23..||Friedrich MG,Abdel-Aty H,Taylor A,Schulz-Menger J,Messroghli D,Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonanceJ Am Coll CardiolYear: 200851161581158710.1016/j.jacc.2008.01.01918420102|
|24..||Beyers RJ,Smith RS,Xu Y,Piras BA,Salerno M,Berr SS,Meyer CH,Kramer CM,French BA,Epstein FH. T2-weighted MRI of post-infarct myocardial edema in miceMagn Reson MedYear: 201267120120910.1002/mrm.2297521630350|
|25..||Beek AM,Nijveldt R,Rossum AC. Intramyocardial hemorrhage and microvascular obstruction after primary percutaneous coronary interventionInt J Cardiovasc ImagingYear: 2010261495510.1007/s10554-009-9499-119757151|
|26..||Ghugre NR,Ramanan V,Pop M,Yang Y,Barry J,Qiang B,Connelly KA,Dick AJ,Wright GA. Quantitative tracking of edema, hemorrhage, and microvascular obstruction in subacute myocardial infarction in a porcine model by MRIMagn Reson MedYear: 20116641129114110.1002/mrm.2285521337425|
|27..||Leonardi B,Margossian R,Colan SD,Powell AJ. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemiaJACC Cardiovasc ImagingYear: 20081557257810.1016/j.jcmg.2008.04.00519356483|
|28..||O’Regan DP,Ahmed R,Karunanithy N,Neuwirth C,Tan Y,Durighel G,Hajnal JV,Nadra I,Corbett SJ,Cook SA. Reperfusion hemorrhage following acute myocardial infarction: assessment with T2* mapping and effect on measuring the area at riskRadiologyYear: 2009250391692210.1148/radiol.250308115419164125|
|29..||Jong S,Zwanenburg JJ,Visser F,Nagel R,Rijen HV,Vos MA,Bakker JM,Luijten PR. Direct detection of myocardial fibrosis by MRIJ Mol Cell CardiolYear: 201151697497910.1016/j.yjmcc.2011.08.02421910997|
|30..||Arslan F,Smeets MB,O’Neill LA,Keogh B,McGuirk P,Timmers L,Tersteeg C,Hoefer IE,Doevendans PA,Pasterkamp G,Kleijn DP. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibodyCirculationYear: 20101211809010.1161/CIRCULATIONAHA.109.88018720026776|
|31..||Heijman E,Graaf W,Niessen P,Nauerth A,Eys G,Graaf L,Nicolay K,Strijkers GJ. Comparison between prospective and retrospective triggering for mouse cardiac MRINMR BiomedYear: 200720443944710.1002/nbm.111017120296|
|32..||Coolen BF,Moonen RP,Paulis LE,Geelen T,Nicolay K,Strijkers GJ. Mouse myocardial first-pass perfusion MR imagingMagn Reson MedYear: 20106461658166310.1002/mrm.2258820928892|
|33..||Bohl S,Lygate CA,Barnes H,Medway D,Stork LA,Schulz-Menger J,Neubauer S,Schneider JE. Advanced methods for quantification of infarct size in mice using three-dimensional high-field late gadolinium enhancement MRIAm J Physiol Heart Circ PhysiolYear: 20092964H1200H120810.1152/ajpheart.01294.200819218501|
|34..||Protti A,Sirker A,Shah AM,Botnar R. Late gadolinium enhancement of acute myocardial infarction in mice at 7T: cine-FLASH versus inversion recoveryJ Magn Reson ImagingYear: 201032487888610.1002/jmri.2232520882618|
|35..||Lund GK,Stork A,Muellerleile K,Barmeyer AA,Bansmann MP,Knefel M,Schlichting U,Muller M,Verde PE,Adam G,Meinertz T,Saeed M. Prediction of left ventricular remodeling and analysis of infarct resorption in patients with reperfused myocardial infarcts by using contrast-enhanced MR imagingRadiologyYear: 200724519510210.1148/radiol.245106121917885184|
|36..||Coolen BF, Simonis FF, Moonen RP, Geelen T, Paulis LE, Nicolay K, Strijkers GJ (2011) T2 mapping of the mouse heart using segmented MLEV supercycle preparation. Montreal, Canada|
|37..||Schneider JE,Cassidy PJ,Lygate C,Tyler DJ,Wiesmann F,Grieve SM,Hulbert K,Clarke K,Neubauer S. Fast, high-resolution in vivo cine magnetic resonance imaging in normal and failing mouse hearts on a vertical 11.7 T systemJ Magn Reson ImagingYear: 200318669170110.1002/jmri.1041114635154|
|38..||Pepe A,Positano V,Santarelli MF,Sorrentino F,Cracolici E,Marchi D,Maggio A,Midiri M,Landini L,Lombardi M. Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overloadJ Magn Reson ImagingYear: 200623566266810.1002/jmri.2056616568436|
|39..||Schwitter J,Saeed M,Wendland MF,Derugin N,Canet E,Brasch RC,Higgins CB. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agentsJ Am Coll CardiolYear: 19973041086109410.1016/S0735-1097(97)00245-39316544|
|40..||Murphy E,Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injuryPhysiol RevYear: 200888258160910.1152/physrev.00024.200718391174|
|41..||Arslan F,Kleijn DP,Timmers L,Doevendans PA,Pasterkamp G. Bridging innate immunity and myocardial ischemia/reperfusion injury: the search for therapeutic targetsCurr Pharm DesYear: 200814121205121610.2174/13816120878424609018473868|
|42..||Bremerich J,Colet JM,Giovenzana GB,Aime S,Scheffler K,Laurent S,Bongartz G,Muller RN. Slow clearance gadolinium-based extracellular and intravascular contrast media for three-dimensional MR angiographyJ Magn Reson ImagingYear: 200113458859310.1002/jmri.108211276103|
|43..||Bogaert J,Bosmans H,Maes A,Suetens P,Marchal G,Rademakers FE. Remote myocardial dysfunction after acute anterior myocardial infarction: impact of left ventricular shape on regional function: a magnetic resonance myocardial tagging studyJ Am Coll CardiolYear: 20003561525153410.1016/S0735-1097(00)00601-X10807456|
|44..||Lessick J,Sideman S,Azhari H,Marcus M,Grenadier E,Beyar R. Regional three-dimensional geometry and function of left ventricles with fibrous aneurysms. A cine-computed tomography studyCirculationYear: 19918431072108610.1161/01.CIR.84.3.10721884440|
|45..||Kramer CM,Lima JA,Reichek N,Ferrari VA,Llaneras MR,Palmon LC,Yeh IT,Tallant B,Axel L. Regional differences in function within noninfarcted myocardium during left ventricular remodelingCirculationYear: 19938831279128810.1161/01.CIR.88.3.12798353890|
|46..||Kramer CM,Rogers WJ,Theobald TM,Power TP,Petruolo S,Reichek N. Remote noninfarcted region dysfunction soon after first anterior myocardial infarction. A magnetic resonance tagging studyCirculationYear: 199694466066610.1161/01.CIR.94.4.6608772685|
|47..||Rademakers F,Werf F,Mortelmans L,Marchal G,Bogaert J. Evolution of regional performance after an acute anterior myocardial infarction in humans using magnetic resonance taggingJ PhysiolYear: 2003546Pt 377778710.1113/jphysiol.2002.02632812563003|
Keywords: Keywords Cardiovascular magnetic resonance, Myocardial infarction, T2*, LGE, Mouse, Fibrosis, Hemorrhage.
Previous Document: Chronic Pancreatitis in India and Asia.
Next Document: Multi-residue analysis of free and conjugated hormones and endocrine disruptors in rat testis by QuE...